{
  "ptid_time": "027_S_4936_2012-12-21",
  "img_path": "/data/qiuhui/data/adni/images/027_S_4936/2012-12-21/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 33,093 mm³, 14.1% below the reference mean. With a Z-score of -0.34 (36.8th percentile), this represents normal volume ; hippocampal volume measures 7,361 mm³, 2.6% below the reference mean. With a Z-score of -0.26 (39.9th percentile), this represents normal volume ; whole brain volume measures 1,092,180 mm³, 1.2% above the reference mean. With a Z-score of 0.15 (56.1th percentile), this represents normal volume ; entorhinal cortex volume measures 4,101 mm³, 0.0% above the reference mean. With a Z-score of 0.00 (50.0th percentile), this represents normal volume ; fusiform gyrus volume measures 18,429 mm³, 2.2% below the reference mean. With a Z-score of -0.19 (42.7th percentile), this represents normal volume ; middle temporal gyrus volume measures 23,911 mm³, 12.1% above the reference mean. With a Z-score of 1.08 (86.1th percentile), this represents mild enlargement. ",
  "text_data": "Age is 78.1 years. Gender is Male. Education: 19 years. Handedness: Right. Race: White. Medical history: Psychiatric; Neurologic; Head, Eyes, Ears, Nose and Throat; Cardiovascular; Dermatologic-Connective Tissue; Musculoskeletal; Renal-Genitourinary; Allergies or Drug Sensitivities; Major Surgical Procedures. MMSE: 27.0. MoCA: 17.0. Logical Memory: 4.0. APOEε4 alleles: 0.0. Biomarker levels: Florbetapir (AV45): 1.48 SUVR (profound elevated); Amyloid beta: 518.30 pg/mL (mild reduced); Total tau: 191.60 pg/mL (normal ); Phosphorylated tau: 18.52 pg/mL (normal ). ",
  "true_diagnosis": "Diagnosis: MCI.",
  "gpt_diagnosis": "**Reasoning:** The brain volumes (hippocampus, entorhinal cortex, fusiform gyrus, and whole brain) are within normal ranges, with only mild enlargement in the middle temporal gyrus. However, the MoCA score of 17 suggests significant cognitive impairment, while the MMSE of 27 is borderline normal. The AV45 (amyloid PET) shows profound elevation, indicating amyloid pathology, but CSF biomarkers (Aβ mildly reduced, normal tau) are not strongly supportive of Alzheimer’s disease.  \n\n**Diagnosis:** **Mild Cognitive Impairment (MCI)** (likely amyloid-positive but with conflicting biomarker profiles)  \n**Confidence:** **Medium** (due to discrepancies between cognitive scores, amyloid imaging, and CSF biomarkers)",
  "timestamp": "2025-07-26T04:03:03.848660"
}